Celebrex Polyp Trial Meta-Analysis Finds CV Risk In Line With Previous Findings
This article was originally published in The Pink Sheet Daily
Executive Summary
Analysis of cardiovascular risk in the APC and PreSAP trials is consistent with current labeling warnings, firm asserts.